Zhejiang Hisun Pharmaceutical Co Ltd (shse:600267) Share Price

Company Profile

Business description
Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.
Contact
No. 46 Waisha Road
Jiaojiang District
Zhejiang Province
Taizhou318000
CHN
T: +86 4001180618
http://www.hisunpharm.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
7,994

Recommended

We’re no longer certain that software firms will outperform over the next decade, but positive outcomes remain possible for names like Salesforce.

Dan Romanoff, CPA | 09 March 2026

We believe AI weakens the competitive advantage of these companies.

Roy Van Keulen | 09 March 2026

Tech saw solid earnings, but there are more questions around which companies will benefit from AI, and which will be hurt.

Rachel Schlueter | 06 March 2026

Index	Last price	Change	% Change
All Ordinaries	8,823.60	16.90	-0.19%
CAC 40	7,915.36	78.13	-0.98%
DAX 40	23,394.38	196.65	-0.83%
Dow JONES (US)	47,706.01	204.46	0.43%
FTSE 100	10,249.52	35.23	-0.34%
HKSE	25,408.46	348.83	-1.35%
NASDAQ	22,677.31	289.63	1.29%
Nikkei 225	52,728.72	2,892.12	-5.20%
NZX 50 Index	13,098.83	519.06	-3.81%
S&P 500	6,790.58	50.56	0.75%
S&P/ASX 200	8,599.00	3.30	-0.04%
SSE Composite Index	4,096.60	27.59	-0.67%